Literature DB >> 20053470

A multicenter study of the association of serum uric acid, serum creatinine, and diuretic use in hypertensive patients.

Chung-Sheng Lin1, Yi-Jen Hung, Gau-Yang Chen, Thing-Fong Tzeng, Du-Yi Lee, Cheng-Yun Chen, Wen-Pin Huang, Chin-Hsung Huang.   

Abstract

BACKGROUND: Individuals with hypertension and hyperuricemia have an increased risk of coronary artery disease and cerebral vascular disease as compared to patients with normal uric acid levels. Our aim is to determine the prevalence of hyperuricemia in hypertensive patients in Taiwan, and whether serum uric acid (SUA) is associated with changes in renal function in patients with hypertension.
METHODS: We studied 2145 hypertensive patients receiving medical treatment, assessed the prevalence of hyperuricemia, and determined the independent risk factors for SUA. Simple correlation and multiple regression analyses were applied to identify the independent risk factors for SUA increase. Logistic regression analysis was used to estimate the association between 4 quartiles of SUA level and correspondent serum creatinine (SCr) concentrations.
RESULTS: Hypertensive subjects had a high prevalence of hyperuricemia (men, 35%; women, 43%). SUA was significantly associated with the independent risk factors of SCr, diuretic usage, and diabetes (inversely related) in both genders, whereas β-blocker usage and body mass index were only associated in men. Multiple logistic regression models showed that in the non-diuretic user group the highest SUA quartile entailed >4 times greater risk for SCr elevation than the lowest. In the diuretic user group, a >2 times greater risk was noted.
CONCLUSIONS: Hyperuricemia hypertensive subjects demonstrated a corresponding elevation of SUA and SCr irrespective of diuretic use. Elevation of SUA, in addition to SCr, may represent a progression of renal function impairment.
Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20053470     DOI: 10.1016/j.ijcard.2009.11.024

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  8 in total

1.  Serum urate in chronic gout--will it be the first validated soluble biomarker in rheumatology?

Authors:  Lisa K Stamp; Puja P Khanna; Nicola Dalbeth; Maarten Boers; Walter P Maksymowych; H Ralph Schumacher; Michael A Becker; Patricia A MacDonald; N Lawrence Edwards; Jasvinder A Singh; Lee S Simon; Fiona M McQueen; Tuhina Neogi; Angelo L Gaffo; Vibeke Strand; William J Taylor
Journal:  J Rheumatol       Date:  2011-07       Impact factor: 4.666

2.  No evidence for a causal link between uric acid and type 2 diabetes: a Mendelian randomisation approach.

Authors:  R Pfister; D Barnes; R Luben; N G Forouhi; M Bochud; K-T Khaw; N J Wareham; C Langenberg
Journal:  Diabetologia       Date:  2011-06-30       Impact factor: 10.122

Review 3.  Allopurinol, uric acid, and oxidative stress in cardiorenal disease.

Authors:  Markus Riegersperger; Adrian Covic; David Goldsmith
Journal:  Int Urol Nephrol       Date:  2011-03-10       Impact factor: 2.370

4.  Association between Hyperuricemia and Metabolic Syndrome: An Epidemiological Study of a Labor Force Population in Taiwan.

Authors:  Cheng-Yu Wei; Chia-Cheng Sun; James Cheng-Chung Wei; Hsu-Chih Tai; Chien-An Sun; Chian-Fang Chung; Yu-Ching Chou; Pi-Li Lin; Tsan Yang
Journal:  Biomed Res Int       Date:  2015-07-26       Impact factor: 3.411

5.  Relationship between uric acid levels and risk of chronic kidney disease in a retrospective cohort of Brazilian workers.

Authors:  L S N Chini; L I S Assis; J R Lugon
Journal:  Braz J Med Biol Res       Date:  2017-08-07       Impact factor: 2.590

Review 6.  Serum Uric Acid and Progression of Kidney Disease: A Longitudinal Analysis and Mini-Review.

Authors:  Ching-Wei Tsai; Shih-Yi Lin; Chin-Chi Kuo; Chiu-Ching Huang
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

7.  Physical exercises and weight loss in obese patients help to improve uric acid.

Authors:  Jun Zhou; Yu Wang; Fan Lian; Dongying Chen; Qian Qiu; Hanshi Xu; Liuqin Liang; Xiuyan Yang
Journal:  Oncotarget       Date:  2017-10-25

8.  A randomized, double-blind, positive-controlled, prospective, dose-response clinical study to evaluate the efficacy and tolerability of an aqueous extract of Terminalia bellerica in lowering uric acid and creatinine levels in chronic kidney disease subjects with hyperuricemia.

Authors:  Usharani Pingali; Chandrasekhar Nutalapati; Niranjan Koilagundla; Gangadhar Taduri
Journal:  BMC Complement Med Ther       Date:  2020-09-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.